Research And Development Tenders

Rv to Provide Prevention Measures in Accordance with Sections 20 Ff Sbg V, Oh Procedure

Medicines with the Active Ingredient Tacrolimus (Atc: L04ad02)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Iron (Ii) Sulfate (B03aa07) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Fingolimod (L04ae01) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Tolvaptan (C03xa01) as Part of a So-Called Open House Model.

Medicines with the Active Ingredient Aclidinium Bromide (Atc: R03bb05)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Fentanyl, only Sublingual Tablets, Nasal Dosage Spray or Lozenges (N02ab03) In...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicinal Products with the Active Ingredient Vilanterol and Fluticasone Furoate (R03ak10) as Part of a So-Called Open-House Mo...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredients Fluticasone and Azelastine (R01ad28) as Part of a So-Called Open House Model.

Medicines with the Active Ingredient Combination Oxycodone and Naloxone (Atc: N02aa55)